Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 4.4B | 4.5B | 4.4B | 4.2B |
Cost of revenue | — | — | — | — |
Gross profit | — | — | — | — |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.4B | 1.8B | 1.3B | 1.4B |
Operating income | — | — | — | — |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 105M | 110M | 114M | 114M |
Other income expense | 1.3B | 1.2B | 1.1B | 1.1B |
Pretax income | 514M | 188M | 550M | 507M |
Tax provision | 122M | -1M | 125M | 112M |
Net income | 392M | 189M | 425M | 395M |
Basic EPS | 1.7 | 0.9 | 1.8 | 1.7 |
Diluted EPS | 1.7 | 0.9 | 1.8 | 1.7 |
Basic average shares | 212.6M | 217.8M | 219.7M | 221.4M |
Diluted average shares | 212.6M | 217.8M | 219.9M | 221.4M |
EBITDA | — | — | — | — |
Net income from continuing op. | 392M | 189M | 425M | 395M |
Minority interests | -22M | -2M | -24M | -26M |
Preferred stock dividends | — | — | — | — |